Your session is about to expire
← Back to Search
Drug Use Module for HIV Infection(4Us Trial)
4Us Trial Summary
This trial is testing whether adding a communication skills training video or a substance use module to couples HIV testing and counseling makes the intervention more effective.
- Human Immunodeficiency Virus (HIV) Infection
- Substance Abuse
4Us Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
4Us Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
4Us Trial Design
Find a Location
Who is running the clinical trial?
- You are a male who has been in a relationship with another male for at least three months.One participant must have used at least 1 drug in the past 90 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB).You have engaged in risky behavior that could lead to transmitting diseases in the last 90 days.You have had unprotected anal sex with someone who is not your regular partner or with a partner who has a different HIV status than you.You have severe mental illness or problems with thinking and memory.You have a history of domestic violence with your current partner, and there are safety concerns regarding your relationship.You have had unprotected anal sex with a casual partner or with a non-monogamous or serodiscordant main partner in the last 90 days.
- Group 1: CHTC as usual
- Group 2: CHTC and communications skills training video
- Group 3: CHTC and substance use module
- Group 4: CHTC, communications skills training and substance use module
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the eligibility requirements for participating in this trial?
"This clinical trial is seeking 480 individuals between the ages of 17 and 29 that present with an HIV diagnosis. In addition to age requirements, participants must have used at least one illicit drug within 90 days prior (e.g., cocaine/crack, opiates, misused prescription medication); be in a relationship with another male for 3 months or longer; and partaken in Transmission Risk Behavior (TRB) during the last 90 day period such as Condom-less Anal Sex (CAS) with either casual partners or non-monogamous/serodiscordant main partner(s)."
Are there any vacancies left in this clinical trial that people can join?
"According to the latest update on clinicaltrials.gov, this medical trial is still recruiting patients; it was initially posted on October 13th 2021 and updated November 24th 2021."
How many subjects have enrolled in the research thus far?
"Affirmative. According to records on clinicaltrials.gov, this medical research was first posted on October 13th 2021 and is now recruiting 480 patients from two distinct sites."
Is eligibility for this experiment limited to those over 35 years of age?
"The requirements for taking part in this trial dictate that the youngest enrollees must be 17 years old, while 30 is the cutoff age."
What is the central goal of this experiment?
"This research project, spanning a period of one year, seeks to measure the primary outcome of CAS with casual partners. Additional objectives include evaluating PrEP Uptake (self-reported receipt of prescription), PrEP Adherence (4+ doses weekly as prescribed) and Syphilis infection (based on bi-annual RPR testing)."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends